Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.33)
# 2,620
Out of 5,050 analysts
334
Total ratings
41.61%
Success rate
-1.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $55.12 | +45.14% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $68.24 | +9.91% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $73.55 | -11.62% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.72 | +196.61% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $33.84 | +195.51% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $27.75 | +62.16% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $31.80 | +135.85% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $14.32 | +109.50% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $18.18 | +142.02% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $17.63 | -43.28% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $17.51 | -42.89% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.52 | +215.13% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $15.09 | +728.36% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $15.04 | -0.27% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.22 | +311.52% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $6.58 | -24.01% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.62 | +38.12% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $8.19 | +83.15% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $26.75 | +68.22% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.47 | +21.46% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.87 | +408.26% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.63 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $2.16 | +224.07% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $3.67 | -18.26% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.53 | +273.97% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.02 | +345.54% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.20 | +257.14% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $68,930,000 | $5.33 | +1,293,245,678.61% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.07 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $55.12
Upside: +45.14%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $68.24
Upside: +9.91%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $73.55
Upside: -11.62%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.72
Upside: +196.61%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $33.84
Upside: +195.51%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $27.75
Upside: +62.16%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $31.80
Upside: +135.85%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $14.32
Upside: +109.50%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $18.18
Upside: +142.02%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $17.63
Upside: -43.28%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $17.51
Upside: -42.89%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $9.52
Upside: +215.13%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $15.09
Upside: +728.36%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $15.04
Upside: -0.27%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.22
Upside: +311.52%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $6.58
Upside: -24.01%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $3.62
Upside: +38.12%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $8.19
Upside: +83.15%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $26.75
Upside: +68.22%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.47
Upside: +21.46%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.87
Upside: +408.26%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $2.16
Upside: +224.07%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $3.67
Upside: -18.26%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.53
Upside: +273.97%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $2.02
Upside: +345.54%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.20
Upside: +257.14%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $68,930,000
Current: $5.33
Upside: +1,293,245,678.61%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $5.07
Upside: -